CLEAN AIR ACT INTERIM EXEMPTIONS FOR OZONE-DEPLETING SUBSTANCES
This article was originally published in The Tan Sheet
Executive Summary
CLEAN AIR ACT INTERIM EXEMPTIONS FOR OZONE-DEPLETING SUBSTANCES are available for medical products considered "potentially essential," FDA says in a notice published in the Dec. 28 Federal Register. "Because of the impending effective dates" of bans on the sale or distribution of certain "nonessential" products that either release a class I ozone- depleting substance into the environment or contain a class II ozone-depleting substance, FDA says it will "consider granting" interim exemptions "based on the filing of a petition" requesting "essential" status for a product.